APA (7th ed.) Citation

A, H., M, B., H, N., T, R., S, S., T, P., . . . I, A. (2025). Absorb® bioresorbable scaffold in "established" versus "off-label" coronary lesions: 5-year data from the GABI-R® registry. Clinical research in cardiology : official journal of the German Cardiac Society, 114(8), 1084. https://doi.org/10.1007/s00392-025-02707-3

Chicago Style (17th ed.) Citation

A, Huseynov, et al. "Absorb® Bioresorbable Scaffold in "Established" Versus "Off-label" Coronary Lesions: 5-year Data from the GABI-R® Registry." Clinical Research in Cardiology : Official Journal of the German Cardiac Society 114, no. 8 (2025): 1084. https://doi.org/10.1007/s00392-025-02707-3.

MLA (9th ed.) Citation

A, Huseynov, et al. "Absorb® Bioresorbable Scaffold in "Established" Versus "Off-label" Coronary Lesions: 5-year Data from the GABI-R® Registry." Clinical Research in Cardiology : Official Journal of the German Cardiac Society, vol. 114, no. 8, 2025, p. 1084, https://doi.org/10.1007/s00392-025-02707-3.